Developer docs
API playgroundTry for free, no card

Search company profiles

ELEVAI Skincare

Full company profile

uuid000jgog

Namestring
ELEVAI Skincare
Legal namestring
Elevai Skincare, Inc.
Company typeenum
Private
Founded yearint
2017
Descriptiontext

ELEVAI Skincare is a Newport Beach, California-based skincare and haircare company that develops and sells biotechnology-driven regenerative products built around its proprietary Cell Zero Exosomes™ technology platform. The platform uses exosomes derived from ethically sourced human umbilical cord mesenchymal stem cells (hUMSCs) and a proprietary liquid-stabilization process that maintains exosome bioactivity without refrigeration or lyophilization. Its core products include Elevai Enfinity™ (an 8-in-1 at-home daily regenerative serum for anti-aging), Elevai Empower™ (a concentrated post-treatment serum designed for clinical use after microneedling, RF microneedling, laser, and chemical peel procedures), and the Root Renewal System™ (a three-step hair and scalp protocol launched in December 2024 in partnership with Yuva Biosciences that combines Cell Zero Exosomes™ with the YuvaBio® Y100™ botanical molecule). Manufacturing is performed in-house in an ISO 7 certified cleanroom under cGMP standards with five validated process stages and independent third-party QC testing.

The company operates a dual go-to-market model. On the clinical side, ELEVAI distributes through a network of more than 300 authorized U.S. clinic providers (dermatologists, plastic surgeons, and aesthetic practitioners) who integrate its products into in-office treatment protocols. On the consumer side, the company sells directly through a Shopify-powered e-commerce storefront (elevaiskincare.com) with a U.S.-only shipping policy, supported by a subscription option for recurring purchases. Pricing is unit-based, with the Root Renewal System™ publicly listed at $299 and professional SKUs priced through authorized provider channels only. ELEVAI Skincare is a wholly owned subsidiary of Elevai Labs Inc. (NASDAQ:ELAB, formerly PMGC), and its co-founder and CEO is Jordan Plews. Corporate and legal correspondence is directed to Pittsburgh, Pennsylvania, while operations and website controls are managed from Newport Beach, California.

The addressable market is the physician-dispensed and consumer exosome skincare category, where the global exosome skincare market is projected to reach US$633.2 million by 2033 at a 9.3% CAGR. ELEVAI competes on differentiated exosome sourcing (umbilical cord-derived rather than adipose-, platelet-, or plant-derived), shelf-stable liquid formulations, and in-house cGMP manufacturing, with brand visibility supported by earned media in Vogue, Marie Claire, Allure, Byrdie, PopSugar, and Beauty Inc.

Short descriptiontext

ELEVAI Skincare is a physician-dispensed and direct-to-consumer skincare company that develops exosome-based regenerative skincare and haircare products powered by its proprietary Cell Zero Exosomes™ technology, selling through 300+ authorized U.S. clinic providers and its own e-commerce platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNewport Beach, United States
HQ citystring
Newport Beach
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
exosome skincare, physician-dispensed skincare, medical aesthetics products, regenerative skincare, hair restoration system
Industry3 codes
PRIMARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRABALAF
Professional Skincare & Facial Treatments
Consumer Products & Retail/Beauty & Personal Care/Professional Salon & Spa Products
NAICS code3 codes
  • Cosmetics, Beauty Supplies, and Perfume Retailers45612
  • Biological Product (except Diagnostic) Manufacturing325414
  • Health and Personal Care Retailers456
SIC code2 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Biological Products, (No Disgnostic Substances)2836
Product category
Medical Aesthetics Skincare
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Professional/Clinical Product Sales
TypeOne Time License
Description

ELEVAI Skincare sells its professional-grade products (Elevai Empower™, Elevai Enfinity™) exclusively through authorized clinic providers. Clinics purchase products for use in in-office aesthetic treatments including microneedling, RF microneedling, laser therapies, and chemical peels. The company requires specific qualifications for provider registration to ensure products are sold under dermatologists or plastic surgeons.

elevaiskincare.com
2Direct-to-Consumer Product Sales
TypeOne Time License
Description

ELEVAI sells consumer products (Elevai Enfinity™ serum, Root Renewal System, Hair Kit) directly to consumers through its e-commerce platform. Consumer products extend and maintain clinical treatment results at home using the same Cell Zero Exosomes™ technology.

elevaiskincare.com
3Subscription Model
TypeSubscription Recurring
Description

The company offers subscription options for consumers to maintain consistent product use, with the messaging 'Subscribe to maintain consistency and unlock your best results' indicating a recurring revenue opportunity.

elevaiskincare.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Operations, Marketing or Sales, Personnel
Pricing details3 tiers
1Root Renewal System™ - 3-step hair and scalp protocol
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$299.00 (sale price). Includes Clarify Treatment Shampoo (150 mL), Nourish Conditioner (150 mL), two bottles of Renew Exosome Scalp Serum, and massage tool. Kit provides 8 weeks of treatment (2 months supply). Free shipping on all orders.

elevaiskincare.com
2Elevai Enfinity™ Exosome Serum
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Price not publicly disclosed on website. Award-winning 8-in-1 regenerative daily serum.

elevaiskincare.com
3Elevai Empower™ Post-Treatment Serum
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Professional-use concentrated serum designed exclusively for clinical settings. Pricing provided through authorized provider channel.

elevaiskincare.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Cell Zero Exosomes™
Description

Proprietary exosome technology platform derived from ethically sourced newborn umbilical stem cells, serving as the core technology powering Elevai's skincare products.

elevaiskincare.com
Core offering1 text field

ELEVAI Skincare develops and sells exosome-based physician-dispensed skincare and haircare products built on its proprietary Cell Zero Exosomes™ platform derived from ethically sourced human umbilical cord mesenchymal stem cells. The company operates a dual-channel model, selling professional-grade products (Elevai Empower™) through a network of 300+ authorized clinics for use in microneedling, RF microneedling, laser, and chemical peel procedures, while also selling consumer products (Elevai Enfinity™ serum and the Root Renewal System™) directly to consumers via its e-commerce store.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Users notice skin feeling calmer and more hydrated within 24-48 hours of first use
+4 more records
Product overview1 text field

ELEVAI Skincare offers a portfolio of exosome-based skincare and haircare products built around its proprietary Cell Zero Exosomes™ technology platform. The core product line includes Elevai Enfinity™ (a daily at-home regenerative serum for anti-aging skincare), Elevai Empower™ (a professional-grade post-treatment serum for in-clinic use after procedures like microneedling and laser), and the Root Renewal System™ (a 3-step hair and scalp protocol). The dual-phase system combines in-office treatments with at-home care, allowing consumers to extend clinical results between provider visits. The company also sells through a network of 300+ authorized clinics.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-12-06
Description

ELEVAI partnered with Yuva Biosciences to develop patent-pending exosome and mitochondrial technology for the S-Series Root Renewal System. This partnership combined Elevai's Cell Zero Exosomes™ technology with YuvaBio® Y100™ botanical molecules to create a three-part hair and scalp care solution targeting hair follicles at the cellular level. The Root Renewal System marks Elevai's first new product launch since 2022, creating new revenue streams and addressing growing demand in the high-growth hair care market.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Physician-dispensed skincare brand (owned by AbbVie/Allergan) that sells growth-factor and regenerative product lines through dermatologists and plastic surgeons — the closest large-scale incumbent to ELEVAI's medical-aesthetics channel strategy.

TypeDirect peer
Description

Biotech-positioned clinical skincare brand sold through physicians and med-spas using defensin-peptide regenerative science, mirroring ELEVAI's scientist-driven, clinic-channel anti-aging positioning.

TypeDirect peer
Description

Professional skincare brand sold through physicians, spas and DTC, known for scientifically formulated regenerative and anti-aging serums — overlapping ELEVAI's dual clinical/DTC channel strategy.

4Calecim Professional
TypeEmerging player
Description

Stem-cell-conditioned-media-based professional skincare line used post-procedure in clinics and med-spas, making it a direct adjacent competitor to ELEVAI's biological skincare offering.

5Plated Skin Science
TypeDirect peer
Description

Regenerative skincare line built around platelet-derived growth-factor technology, sold via physicians and DTC; competes with ELEVAI on the 'biologically active, exosome-adjacent' skincare narrative.

TypeDirect peer
Description

Dr. Obagi's physician-dispensed skincare line sold through dermatologists and med-spas with a strong anti-aging and post-procedure focus, overlapping ELEVAI's clinical channel.

TypeDirect peer
Description

Glycomics-based skincare sold through dermatologists and plastic surgeons, positioning itself on biotech active ingredients and post-procedure care, overlapping with ELEVAI's Enfinity™/Empower™ use cases.

8BENEV
TypeDirect peer
Description

Medical-grade skincare and exosome-based regenerative products sold to physicians and med-spas; competes head-to-head with Cell Zero Exosomes™ in microneedling and post-laser protocols.

9SkinCeuticals
TypeBroad incumbent
Description

L'Oréal-owned physician-recommended skincare brand with a wide antioxidant and post-procedure portfolio; competes with ELEVAI for clinic shelf space in dermatology and plastic-surgery practices.

10Alastin Skincare
TypeDirect peer
Description

Galderma-owned physician-dispensed brand built around post-procedure and regenerative skincare (e.g., TriHex Technology) distributed through dermatology and plastic-surgery clinics, directly overlapping ELEVAI's professional channel and post-treatment use cases.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ELEVAI Skincare

Medical Aesthetics Skincareelevaiskincare.com

ELEVAI Skincare is a physician-dispensed and direct-to-consumer skincare company that develops exosome-based regenerative skincare and haircare products powered by its proprietary Cell Zero Exosomes™ technology, selling through 300+ authorized U.S. clinic providers and its own e-commerce platform.

What ELEVAI Skincare does

ELEVAI Skincare is a Newport Beach, California-based skincare and haircare company that develops and sells biotechnology-driven regenerative products built around its proprietary Cell Zero Exosomes™ technology platform. The platform uses exosomes derived from ethically sourced human umbilical cord mesenchymal stem cells (hUMSCs) and a proprietary liquid-stabilization process that maintains exosome bioactivity without refrigeration or lyophilization. Its core products include Elevai Enfinity™ (an 8-in-1 at-home daily regenerative serum for anti-aging), Elevai Empower™ (a concentrated post-treatment serum designed for clinical use after microneedling, RF microneedling, laser, and chemical peel procedures), and the Root Renewal System™ (a three-step hair and scalp protocol launched in December 2024 in partnership with Yuva Biosciences that combines Cell Zero Exosomes™ with the YuvaBio® Y100™ botanical molecule). Manufacturing is performed in-house in an ISO 7 certified cleanroom under cGMP standards with five validated process stages and independent third-party QC testing.

The company operates a dual go-to-market model. On the clinical side, ELEVAI distributes through a network of more than 300 authorized U.S. clinic providers (dermatologists, plastic surgeons, and aesthetic practitioners) who integrate its products into in-office treatment protocols. On the consumer side, the company sells directly through a Shopify-powered e-commerce storefront (elevaiskincare.com) with a U.S.-only shipping policy, supported by a subscription option for recurring purchases. Pricing is unit-based, with the Root Renewal System™ publicly listed at $299 and professional SKUs priced through authorized provider channels only. ELEVAI Skincare is a wholly owned subsidiary of Elevai Labs Inc. (NASDAQ:ELAB, formerly PMGC), and its co-founder and CEO is Jordan Plews. Corporate and legal correspondence is directed to Pittsburgh, Pennsylvania, while operations and website controls are managed from Newport Beach, California.

The addressable market is the physician-dispensed and consumer exosome skincare category, where the global exosome skincare market is projected to reach US$633.2 million by 2033 at a 9.3% CAGR. ELEVAI competes on differentiated exosome sourcing (umbilical cord-derived rather than adipose-, platelet-, or plant-derived), shelf-stable liquid formulations, and in-house cGMP manufacturing, with brand visibility supported by earned media in Vogue, Marie Claire, Allure, Byrdie, PopSugar, and Beauty Inc.

ELEVAI Skincare firmographics

Firmographics
Name
ELEVAI Skincare
Legal name
Elevai Skincare, Inc.
Website
https://elevaiskincare.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
ELEVAI Skincare is a physician-dispensed and direct-to-consumer skincare company that develops exosome-based regenerative skincare and haircare products powered by its proprietary Cell Zero Exosomes™ technology, selling through 300+ authorized U.S. clinic providers and its own e-commerce platform.
Ownership category
akta.pro rank

ELEVAI Skincare industry classification

Industry
Product category
Medical Aesthetics Skincare
NAICS
Cosmetics, Beauty Supplies, and Perfume Retailers (45612), Biological Product (except Diagnostic) Manufacturing (325414), Health and Personal Care Retailers (456)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRABALAF
Professional Skincare & Facial Treatments
Consumer Products & Retail/Beauty & Personal Care/Professional Salon & Spa Products

Keywords

  • Exosome skincare
  • Physician-dispensed skincare
  • Medical aesthetics products
  • Regenerative skincare
  • Hair restoration system

Where ELEVAI Skincare is headquartered

Location

Headquarters

HQ city
Newport Beach
HQ country
United States
HQ region
North America

Offices3 records

Markets served

ELEVAI Skincare business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Operations, Marketing or Sales, Personnel

Revenue model

  1. Professional/Clinical Product Sales: ELEVAI Skincare sells its professional-grade products (Elevai Empower™, Elevai Enfinity™) exclusively through authorized clinic providers. Clinics purchase products for use in in-office aesthetic treatments including microneedling, RF microneedling, laser therapies, and chemical peels. The company requires specific qualifications for provider registration to ensure products are sold under dermatologists or plastic surgeons.
  2. Direct-to-Consumer Product Sales: ELEVAI sells consumer products (Elevai Enfinity™ serum, Root Renewal System, Hair Kit) directly to consumers through its e-commerce platform. Consumer products extend and maintain clinical treatment results at home using the same Cell Zero Exosomes™ technology.
  3. Subscription Model: The company offers subscription options for consumers to maintain consistent product use, with the messaging 'Subscribe to maintain consistency and unlock your best results' indicating a recurring revenue opportunity.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goRoot Renewal System™ - 3-step hair and scalp protocol
Unit PricingPay-as-you-goElevai Enfinity™ Exosome Serum
Unit PricingPay-as-you-goElevai Empower™ Post-Treatment Serum

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

ELEVAI Skincare product offering

Product offering

Core offering

ELEVAI Skincare develops and sells exosome-based physician-dispensed skincare and haircare products built on its proprietary Cell Zero Exosomes™ platform derived from ethically sourced human umbilical cord mesenchymal stem cells. The company operates a dual-channel model, selling professional-grade products (Elevai Empower™) through a network of 300+ authorized clinics for use in microneedling, RF microneedling, laser, and chemical peel procedures, while also selling consumer products (Elevai Enfinity™ serum and the Root Renewal System™) directly to consumers via its e-commerce store.

Product overview

ELEVAI Skincare offers a portfolio of exosome-based skincare and haircare products built around its proprietary Cell Zero Exosomes™ technology platform. The core product line includes Elevai Enfinity™ (a daily at-home regenerative serum for anti-aging skincare), Elevai Empower™ (a professional-grade post-treatment serum for in-clinic use after procedures like microneedling and laser), and the Root Renewal System™ (a 3-step hair and scalp protocol). The dual-phase system combines in-office treatments with at-home care, allowing consumers to extend clinical results between provider visits. The company also sells through a network of 300+ authorized clinics.

Differentiator

Problem solved

Functional benefit

Brands

  • Cell Zero Exosomes™: Proprietary exosome technology platform derived from ethically sourced newborn umbilical stem cells, serving as the core technology powering Elevai's skincare products.

Quantifiable outcome

  • Users notice skin feeling calmer and more hydrated within 24-48 hours of first use
  • +4 more outcomes

Companies that use ELEVAI Skincare

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

ELEVAI Skincare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

ELEVAI Skincare partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Yuva BiosciencescoreStrategic or Co-development Partner · 6 December 2024ELEVAI partnered with Yuva Biosciences to develop patent-pending exosome and mitochondrial technology for the S-Series Root Renewal System. This partnership combined Elevai's Cell Zero Exosomes™ technology with YuvaBio® Y100™ botanical molecules to create a three-part hair and scalp care solution targeting hair follicles at the cellular level. The Root Renewal System marks Elevai's first new product launch since 2022, creating new revenue streams and addressing growing demand in the high-growth hair care market.

Scale indicators6 records

Recent moves4 records

Expansion highlights5 records

ELEVAI Skincare competitors and assessment

Company assessment

Broad incumbents

  • SkinMedica: Physician-dispensed skincare brand (owned by AbbVie/Allergan) that sells growth-factor and regenerative product lines through dermatologists and plastic surgeons — the closest large-scale incumbent to ELEVAI's medical-aesthetics channel strategy.
  • SkinCeuticals: L'Oréal-owned physician-recommended skincare brand with a wide antioxidant and post-procedure portfolio; competes with ELEVAI for clinic shelf space in dermatology and plastic-surgery practices.

Direct peers

  • DefenAge: Biotech-positioned clinical skincare brand sold through physicians and med-spas using defensin-peptide regenerative science, mirroring ELEVAI's scientist-driven, clinic-channel anti-aging positioning.
  • iS Clinical: Professional skincare brand sold through physicians, spas and DTC, known for scientifically formulated regenerative and anti-aging serums — overlapping ELEVAI's dual clinical/DTC channel strategy.
  • Plated Skin Science: Regenerative skincare line built around platelet-derived growth-factor technology, sold via physicians and DTC; competes with ELEVAI on the 'biologically active, exosome-adjacent' skincare narrative.
  • ZO Skin Health: Dr. Obagi's physician-dispensed skincare line sold through dermatologists and med-spas with a strong anti-aging and post-procedure focus, overlapping ELEVAI's clinical channel.
  • Senté Laboratories: Glycomics-based skincare sold through dermatologists and plastic surgeons, positioning itself on biotech active ingredients and post-procedure care, overlapping with ELEVAI's Enfinity™/Empower™ use cases.
  • BENEV: Medical-grade skincare and exosome-based regenerative products sold to physicians and med-spas; competes head-to-head with Cell Zero Exosomes™ in microneedling and post-laser protocols.
  • Alastin Skincare: Galderma-owned physician-dispensed brand built around post-procedure and regenerative skincare (e.g., TriHex Technology) distributed through dermatology and plastic-surgery clinics, directly overlapping ELEVAI's professional channel and post-treatment use cases.

Emerging players

  • Calecim Professional: Stem-cell-conditioned-media-based professional skincare line used post-procedure in clinics and med-spas, making it a direct adjacent competitor to ELEVAI's biological skincare offering.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights5 records

Customer concentration

ELEVAI Skincare social profiles

Digital presence

ELEVAI Skincare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ELEVAI Skincare leadership team

Management profile

Number of profiles

Profiles1 record

ELEVAI Skincare funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ELEVAI Skincare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ELEVAI Skincare

What does ELEVAI Skincare do?

ELEVAI Skincare develops and sells exosome-based physician-dispensed skincare and haircare products built on its proprietary Cell Zero Exosomes™ platform derived from ethically sourced human umbilical cord mesenchymal stem cells. The company operates a dual-channel model, selling professional-grade products (Elevai Empower™) through a network of 300+ authorized clinics for use in microneedling, RF microneedling, laser, and chemical peel procedures, while also selling consumer products (Elevai Enfinity™ serum and the Root Renewal System™) directly to consumers via its e-commerce store.

Is ELEVAI Skincare a public or private company?

ELEVAI Skincare is a private company. It is classified as corporate owned and is currently operating.

When was ELEVAI Skincare founded?

ELEVAI Skincare was founded in 2017. It employs 1 to 10 people.

Where is ELEVAI Skincare based?

ELEVAI Skincare is headquartered in Newport Beach, United States, in the North America region.

How does ELEVAI Skincare make money?

Three revenue lines are on record. Professional/Clinical Product Sales are the primary driver. The others are direct-to-Consumer Product Sales and subscription Model.

Who are ELEVAI Skincare's main competitors?

Broad incumbents on record are SkinMedica and SkinCeuticals. Direct peers are DefenAge, iS Clinical, Plated Skin Science, ZO Skin Health, Senté Laboratories, BENEV and Alastin Skincare. Calecim Professional is listed as an emerging player.

Does ELEVAI Skincare have an API?

No public API is recorded for ELEVAI Skincare.

What industry is ELEVAI Skincare in?

ELEVAI Skincare's product category is Medical Aesthetics Skincare. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 45612 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswirePMGC Holdings Inc. Announces Closing of Elevai Skincare DivestiturePMGC Holdings closed its divestiture of Elevai Skincare to Carmell, receiving approximately 1.26 million Carmell shares, $57,000 cash, and Carmell's assumption of Elevai's liabilities. The deal includes a 5% net sales royalty and a $500,000 milestone payment if Elevai's hair and scalp products reach $500,000 in net revenue within 24 months.BenzingaDow Surges Over 300 Points; US Initial Jobless Claims Decline - Baird Medical Investment (NASDAQ:BDMD)U.S. stocks traded higher on Thursday, with the Dow Jones index gaining over 300 points (0.80%) and the NASDAQ rising 0.84%, as initial jobless claims fell to 211,000, beating market estimates of 222,000. Notable individual stock movements included Carmell Corporation surging 274% after announcing an agreement to acquire Elevai Skincare, while Neumora Therapeutics dropped 80% after its Phase 3 KOASTAL study failed to meet its primary endpoint. The S&P Global manufacturing PMI declined to 49.4 in December, signaling continued contraction in the manufacturing sector.AInvestCarmell's Strategic Acquisition: A New Era in Bio-AestheticsCarmell Corporation agreed to acquire Elevai Skincare, a provider of exosome-based skin and hair care products. The deal includes Elevai's product portfolio, team, and inventory, with the company reporting $2.5 million in trailing revenue. The acquisition aims to integrate exosome technology into Carmell's platform for future product innovation.Quiver QuantitativeElevai Skincare Launches Innovative S-Series Root Renewal System for Hair and Scalp HealthElevai Skincare Inc., a wholly owned subsidiary of Elevai Labs Inc., has launched the S-Series Root Renewal System, a three-part hair and scalp care solution incorporating patent-pending exosome and mitochondrial technology developed in partnership with Yuva Biosciences. The system, designed to target hair follicles at the cellular level, marks Elevai Skincare's first new product launch since 2022, with initial availability through select medical aesthetics partners in the United States ahead of a broader consumer rollout in January 2025. The launch is intended to create new revenue streams and growth opportunities for Elevai Labs, addressing growing demand in the high-growth hair care market.GlobeNewswireElevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care MarketElevai Skincare launched the S-Series Root Renewal System, a three-part hair and scalp care system combining exosome and mitochondrial technologies. The product will initially be sold through medical aesthetics partners, with a full e-commerce launch planned for January 2025.GlobeNewswireElevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care MarketElevai Skincare launched the S-Series Root Renewal System, a three-part hair and scalp care system combining exosome and mitochondrial technologies. The product will debut through medical aesthetics partners in select U.S. accounts, with full e-commerce sales planned for January 2025.GlobeNewswireElevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare DivisionElevai Skincare achieved record monthly sales in November 2024, exceeding the previous four-month average by 65%. The revenue of $300K was driven by performance-based incentives and streamlined operations. The company expects strong year-end performance as it enters the holiday season.GlobeNewswireElevai Labs Inc. Subsidiary, Elevai Skincare Inc.,Elevai Labs announced a clinical study to test its exosome skincare products with energy-based aesthetic devices on facial skin. The study will enroll up to 20 subjects aged 35-75 and expects topline data by Q1 2025. The company is seeking partnerships with energy device companies to further validate the combination.GlobeNewswireElevai Labs Inc. Subsidiary, Elevai Skincare Inc.,Elevai Labs announced a clinical study to test its exosome skincare products with energy-based aesthetic devices on facial skin. The study will enroll up to 20 subjects aged 35-75 and expects to announce topline data by Q1 2025.Stock TitanElevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy DeviceElevai Skincare Inc. launched a clinical study combining its topical exosome products with an energy device for facial skin rejuvenation. The study enrolls up to 20 subjects aged 35-75, measuring tolerability and improvement over 12 weeks. Elevai expects to announce topline data by Q1 2025.